1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNo fixed deadline mentioned; contact-based application process suggests rolling
NYU Langone Health Venture Fund is sponsored by NYU Langone Health. Provides strategic seed stage investments to biomedical startups that leverage technologies and intellectual property developed at NYU. Offers an ecosystem to drive success.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NYU Langone Health Venture Fund - Technology Opportunities & Ventures by NYU and NYU Langone Health NYU Langone Health Venture Fund NYU Langone Health Venture Fund Commercialization Process Intellectual Property 101 NYU Innovators’ “Bill of Rights” Therapeutics Alliances (Innovators) Therapeutics Alliances Request for Proposals MedTech Venture Prototyping Technology Acceleration & Commercialization Awards NYU Langone Health Venture Fund Biomedical Entrepreneurship Program Biomedical Entrepreneurship Program Courses The NYU Langone Health Venture Fund provides strategic seed-stage investments to biomedical startups that leverage technologies and IP developed at NYU, including companies developing drugs, diagnostics, medical devices, and healthtech solutions.
With a deep understanding of the healthcare landscape and a commitment to innovation, we offer more than just capital—we provide an ecosystem to drive success. What sets the NYU Langone Health Venture Fund apart?
Healthcare investors with a diverse skillset: Our investment committee is comprised of experienced professionals with a broad range of backgrounds, including practicing physicians, medical researchers, hospital administrators, finance professionals, and biotech executives. We understand the unique challenges and opportunities that healthcare startups face, enabling us to offer tailored guidance to our portfolio companies.
Seed stage focus: We specialize in seed stage investments, recognizing the importance of early-stage funding in propelling healthcare ventures from concept to patients. Value-added support: Beyond financing, we aid our portfolio companies in business development initiatives and by providing access to our network of medical experts.
A strong, focused team: We want leaders with domain expertise who understand the technical, operational, and regulatory challenges in bringing a clinical product to market. We value transparency and management’s ability to communicate promptly and succinctly. Impactful healthcare solutions: Our investment focus is centered around companies that have the potential to address significant unmet needs.
We look for technology that is differentiated, and for entrepreneurs who can articulate the value of their product and how it fits within a competitive landscape. Scientific validation: For therapeutics, we look for a clear mechanism of action and supportive preclinical data. For diagnostics, medical devices, or healthtech solutions, we look for prototypes that can provide early evidence of clinical benefit.
Settled IP: We expect startups to have completed licensing discussions and have access to IP with strong claims that provide freedom to operate. A well-thought-out business model: Management should have a firm grasp of near-term expenses and funds required to advance programs to market. Preliminary market sizing analysis should also be conducted that shows an understanding of addressable commercial opportunities.
Our overriding mission is to help convert the groundbreaking medical discoveries made within the halls of NYU into tangible benefits for patients. If you are a healthcare entrepreneur leveraging NYU IP, contact TOV to learn more about how we can help turn your vision into reality.
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Biomedical startups that leverage technologies and IP developed at NYU. Confirm the full requirements in the official notice before applying.
NYU Langone Health Venture Fund is funded by NYU Langone Health. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article